As of January 23, 2025, Petros Pharmaceuticals (PTPI) has a market cap of $3.099 million USD. According to our data, Petros Pharmaceuticals is ranked No.9141 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $3.10 M |
-21.47%
|
Dec 31, 2024 | $3.95 M |
-72.06%
|
Dec 29, 2023 | $14.12 M |
-39.48%
|
Dec 30, 2022 | $23.33 M |
-93.00%
|
Dec 31, 2021 | $0.33 B |
-24.32%
|
Dec 31, 2020 | $0.44 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Viatris
VTRS
|
$13.30 B |
-0.000 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Market Cap | = | PTPI Stock Price | * | PTPI Shares Outstanding |
= | $0.31 | * | 10.01 M | |
= | $3.10 M |